Other Segment: Lower Revenue, Higher Profit
First written in FY2018-Q1. . Latest entry: FY2027-H1.
The whole theme swung hardest in 2020: 5 of 11 companies on the "Worse" side.
2 other companies' latest entry also says "Other".
- FY2027-H1Substantial revenue and profit declines in the interim periodAnnual report
「Due to a decrease in content sales revenue, revenue from the Other segment totaled ¥53 million, down 69.6% year on year, and interim profit before tax totaled ¥20 million, down 57.3%.」
In the interim period of FY2027, revenue in the Other segment decreased 69.6% and interim profit before tax decreased 57.3% due to lower content sales revenue. - 2026-07-08OtherEarnings
「Revenue from the Other segment amounted to ¥26 million, down 68.8% year on year, and profit before tax amounted to ¥9 million, down 37.2%, due to a decrease in content sales revenue following the partial transfer of the content business.」
For the Other segment, first-quarter results were updated to reflect lower revenue and profit following the partial transfer of the content business. - FY2026Full-year revenue decline and return to profitabilityAnnual report
「Due to lower content sales revenue, revenue in the Other segment was ¥270 million, down 34.4% year on year. Meanwhile, profit before tax was ¥603 million, compared with a loss of ¥856 million in the previous consolidated fiscal year, due to the transfer of part of the Content business through an absorption-type company split.」
The Other segment posted lower revenue due to declining content sales revenue, while profit before tax turned positive at ¥603 million due to the transfer of part of the Content business. - FY2026-H1Lower revenue and profit for the six-month periodAnnual report
「Due to lower content sales revenue, revenue in the Other segment was ¥176 million, down 21.0% year on year, while interim profit before tax was ¥48 million, down 22.8%.」
The Other segment posted a 21.0% decline in revenue and a 22.8% decline in interim profit before tax due to declining content sales revenue. - FY2025Full-year revenue decline and a swing to a lossAnnual report
「Following a decline in content sales revenue, an impairment test on goodwill attributable to the Content business resulted in an impairment loss of ¥1,012 million. As a result, revenue in the Other segment was ¥411 million, down 32.6% year on year, while the segment recorded a loss before tax of ¥856 million, compared with profit of ¥240 million in the previous consolidated fiscal year.」
The Other segment changed to lower full-year revenue and a loss due to declining content sales revenue and a ¥1,012 million impairment loss on goodwill. - FY2025-H1Lower revenue and profit continued in the first halfAnnual report
「Due to lower content sales revenue, revenue in the Other segment was ¥223 million, down 35.8% year on year, while interim profit before tax was ¥62 million, down 42.0%.」
The Other segment posted a 35.8% decline in revenue and a 42.0% decline in interim profit before tax for the six-month period due to declining content sales revenue. - FY2025-Q1Lower revenue and profit continued in the first quarterAnnual report
「Due to lower content sales revenue, revenue in the Other segment was ¥107 million, down 37.9% year on year, while quarterly profit before tax was ¥21 million, down 50.5%.」
The Other segment posted lower revenue and profit in the first quarter of FY2025 due to declining content sales revenue. - FY2024-Q3Lower revenue and profit continued through the first 9 monthsAnnual report
「Due to lower content sales revenue, revenue in the Other segment was ¥488 million, down 30.1% year on year, while quarterly profit before tax was ¥181 million, down 10.8%.」
The Other segment posted a 30.1% decline in revenue and a 10.8% decline in quarterly profit before tax for the nine months ended due to declining content sales revenue. - FY2024-Q2Revenue and profit down for the six months ended second quarterAnnual report
「Due to lower content sales revenue, revenue in the Other segment was ¥347 million, down 28.1% year on year, while quarterly profit before tax was ¥106 million, down 4.1%.」
The Other segment posted lower revenue and profit for the six months ended due to declining content sales revenue. - FY2024-Q1Lower revenue and profit continued in the first quarterAnnual report
「Due to lower content sales revenue, revenue in the Other segment was ¥172 million, down 28.9% year on year, while quarterly profit before tax was ¥43 million, down 31.8%.」
The Other segment posted lower revenue and profit in the first quarter due to declining content sales revenue. - FY2023Full-year revenue decline and return to profitabilityAnnual report
「Due to lower content sales revenue, revenue in the Other segment was ¥896 million, down 11.6% year on year. Profit before tax increased by ¥420 million year on year to ¥257 million.」
The Other segment posted lower revenue due to declining content sales revenue, while profit before tax turned positive at ¥257 million due to the reversal of the previous year's impairment loss on ポッケ’s goodwill. - FY2023-Q3Lower revenue and profit continued through the first 9 monthsAnnual report
「Due to lower content sales revenue, revenue in the Other segment was ¥698 million, down 8.8% year on year, while quarterly profit before tax was ¥203 million, down 21.0%.」
The Other segment posted lower revenue and profit for the nine months ended due to declining content sales revenue. - FY2023-Q2Revenue and profit down for the six months ended second quarterAnnual report
「Due to lower content sales revenue, revenue in the Other segment was ¥482 million, down 5.4% year on year, while quarterly profit before tax was ¥111 million, down 31.3%.」
The Other segment posted lower revenue and profit for the six months ended due to declining content sales revenue. Revenue fell 5.4% and quarterly profit before tax fell 31.3%. - FY2023-Q1Lower revenue and profit continued in the first quarterAnnual report
「Due to lower content sales revenue, revenue in the Other segment was ¥242 million, down 2.1% year on year, while quarterly profit before tax was ¥63 million, down 19.9%.」
The Other segment posted lower revenue and profit in the first quarter due to declining content sales revenue. - FY2022-Q3Revenue down and profit up for the nine months ended third quarterAnnual report
「Despite lower content sales revenue, improved profitability through a review of expenses and other measures resulted in revenue of ¥768 million in the Other segment, down 13.4% year on year, while quarterly profit before tax was ¥349 million, up 73.3%.」
The Other segment continued to post lower revenue due to declining content sales revenue, while improved profitability through a review of expenses and other measures drove a 73.3% increase in profit before tax for the nine months ended. - FY2022-Q2Revenue down and profit up for the six months ended second quarterAnnual report
「Despite lower content sales revenue, improved profitability through a review of expenses and other measures resulted in revenue of ¥511 million in the Other segment, down 15.0% year on year, while quarterly profit before tax was ¥213 million, up 64.5%.」
The Other segment continued to post lower revenue due to declining content sales revenue, while improved profitability through a review of expenses drove a 64.5% increase in profit before tax for the six months ended. - FY2022-Q1Revenue decline and continued profit growth in the first quarterAnnual report
「Despite lower content sales revenue, improved profitability through a review of expenses and other measures resulted in revenue of ¥248 million in the Other segment, down 15.7% year on year, while quarterly profit before tax was ¥102 million, up 97.7%.」
The Other segment continued to post lower revenue due to declining content sales revenue, while improved profitability through a review of expenses drove a 97.7% increase in first-quarter profit before tax. It changed from a loss in the previous full fiscal year to recording a profit. - FY2021Sharp full-year revenue decline and a swing to a lossAnnual report
「Revenue declined due to the transfer of the CSO business, which was included in the Other business in the previous consolidated fiscal year, and lower content sales revenue. In addition, an impairment test on goodwill attributable to consolidated subsidiary 株式会社ポッケ resulted in an impairment loss of ¥854 million. As a result, revenue in the Other segment was ¥1,176 million, down 22.7% year on year, while the segment recorded a loss before tax of ¥568 million, compared with profit of ¥127 million in the previous consolidated fiscal year.」
The Other segment saw lower revenue due to the transfer of the CSO business and lower content sales revenue, and turned to a full-year loss before tax due to an impairment loss on ポッケ’s goodwill. - FY2021-Q3Substantial revenue decline and higher profit for the nine months ended third quarterAnnual report
「Due to the transfer of the CSO business, which was included in the Other business in the previous consolidated fiscal year, and lower content sales revenue, revenue in the Other segment was ¥887 million, down 25.5% year on year, while quarterly profit before tax was ¥201 million, up 134.2%.」
The Other segment saw a sharp revenue decline due to the transfer of the CSO business and lower content sales revenue, while quarterly profit before tax increased 134.2%. - FY2021-Q2Sharp revenue decline and higher profit in the six months endedAnnual report
「Due to the transfer of the CSO business, which was included in the Other business in the previous consolidated fiscal year, and lower content sales revenue, revenue in the Other segment was ¥602 million, down 31.3% year on year, while quarterly profit before tax was ¥130 million, up 162.8%.」
The Other segment saw a sharp revenue decline due to the transfer of the CSO business and lower content sales revenue, while quarterly profit before tax increased 162.8%. - FY2021-Q1Sharp revenue decline and higher profit in the first quarterAnnual report
「Due to the transfer of the CSO business, which was included in the Other business in the previous consolidated fiscal year, and lower content sales revenue, revenue in the Other segment was ¥294 million, down 44.7% year on year, while quarterly profit before tax was ¥52 million, up 305.7%.」
The Other segment saw a sharp revenue decline due to the transfer of the CSO business and lower content sales revenue, while quarterly profit before tax increased 305.7%. - FY2020Substantial full-year revenue decline and return to profitabilityAnnual report
「Following the transfer of the CSO business (Contract Sales Organization) of ㈱ビーアイメディカル and the exclusion of 株式会社BELL24・Cell Product (hereinafter, “㈱BELL24・Cell Product”) from consolidation, as well as a decline in content sales revenue in the Other business, revenue in the Other segment was ¥1,521 million, down 58.3% year on year. On the earnings side, profit before tax was ¥127 million, compared with a loss of ¥1,431 million in the previous consolidated fiscal year, mainly due to the reversal of one-off losses related to the business restructuring carried out in the previous consolidated fiscal year.」
Revenue declined sharply due to the transfer of the CSO business, the exclusion of BELL24・Cell Product from consolidation and lower content sales revenue, while profit before tax turned positive on the reversal of business restructuring losses. - FY2020-Q3Substantial revenue decline and higher profit for the nine months ended third quarterAnnual report
「In addition to the transfer of the CSO business of B.I. Medical Co., Ltd. and the removal of BELL24 and Cell Product from the scope of consolidation, lower content sales revenue in the Other businesses and other factors resulted in revenue of ¥1,191 million in the Other segment, down 57.6% year on year, while quarterly profit before tax was ¥86 million, up 4.9%.」
The Other segment reported a substantial decline in revenue for the nine months ended the third quarter, while quarterly profit before tax increased 4.9% year on year. The transfer of the CSO business, the removal of BELL24 and Cell Product from the scope of consolidation, and lower content sales revenue were cited as factors behind the revenue decline. - FY2020-Q2Revenue down and loss continues for the six months ended second quarterAnnual report
「In addition to the transfer of the CSO business of B.I. Medical Co., Ltd. and the removal of BELL24 and Cell Product from the scope of consolidation, lower content sales revenue in the Other businesses and other factors resulted in revenue of ¥2,416 million in the Other segment, down 27.7% year on year, and a quarterly loss before tax of ¥29 million, compared with quarterly profit before tax of ¥106 million in the previous year.」
The Other segment reported lower revenue and a loss for the six months ended the second quarter, owing to the transfer of the CSO business, the removal of BELL24 and Cell Product from the scope of consolidation, and lower content sales revenue. - FY2020-Q1First-quarter revenue down and loss reportedAnnual report
「In addition to the transfer of the CSO business of B.I. Medical Co., Ltd. and the removal of BELL24 and Cell Product from the scope of consolidation, lower content sales revenue in the Other businesses and other factors resulted in revenue of ¥1,298 million in the Other segment, down 23.2% year on year, and a quarterly loss before tax of ¥17 million, compared with quarterly profit before tax of ¥64 million in the previous year.」
The Other segment reported lower revenue and a loss in the first quarter, owing to the transfer of the CSO business, the removal of BELL24 and Cell Product from the scope of consolidation, and lower content sales revenue. - FY2019Full-year revenue down and loss reportedAnnual report
「Other expenses increased substantially because of the transfer of the CSO business and the transfer of shares in BELL24 and Cell Product. As a result, the loss before tax was ¥1,458 million, compared with profit before tax of ¥356 million in the previous consolidated fiscal year.」
The Other segment reported a full-year loss before tax because of costs related to the business transfer, in addition to lower CSO orders and content sales revenue. - FY2019-Q3Lower revenue and profit continued through the first 9 monthsAnnual report
「Due mainly to lower orders in the CSO (contract sales organization) business and lower content sales revenue in the Other businesses, revenue in the Other segment was ¥4,830 million, down 5.1% year on year, while quarterly profit before tax was ¥94 million, down 69.8%.」
The Other segment reported lower revenue and profit for the nine months ended the third quarter, owing mainly to lower orders in the CSO business and lower content sales revenue. - FY2019-Q2Revenue and profit down for the six months ended second quarterAnnual report
「Due mainly to lower orders in the CSO (contract sales organization) business and lower content sales revenue in the Other businesses, revenue in the Other segment was ¥3,343 million, down 3.1% year on year, while quarterly profit before tax was ¥106 million, down 54.3%.」
The Other segment reported lower revenue and profit for the six months ended the second quarter, owing mainly to lower orders in the CSO business and lower content sales revenue. - FY2019-Q1First-quarter revenue and profit downAnnual report
「Due mainly to lower orders in the CSO (contract sales organization) business and lower content sales revenue in the Other businesses, revenue in the Other segment was ¥1,690 million, down 2.9% year on year, while quarterly profit before tax was ¥64 million, down 62.4%.」
The Other segment reported lower revenue and profit in the first quarter, owing mainly to lower orders in the CSO business and lower content sales revenue. - FY2018Lower revenue and higher earnings for the full yearAnnual report
「As a result, revenue in the Other segment was ¥6,750 million, down 8.7% year on year, while profit before tax was ¥356 million, up 21.7%.」
The Other segment reported lower full-year revenue and higher profit, with the reversal of one-off losses associated with the business reorganization and other factors contributing to the increase in profit. - FY2018-Q3Revenue down and profit up for the nine months ended third quarterAnnual report
「Although the business reorganization in the previous consolidated fiscal year contributed revenue from the provision of medical representatives (MRs) to pharmaceutical companies, the substantial decline in revenue from the pharmaceutical development support business resulted in lower revenue year on year. On the profit side, quarterly profit before tax increased year on year, mainly because of the reversal of a one-off loss related to the business reorganization in the nine months ended the third quarter of the previous fiscal year. As a result, revenue in the Other segment was ¥5,087 million, down 7.9% year on year, while quarterly profit before tax was ¥314 million, up 107.1%.」
The Other segment reported lower revenue and higher profit for the nine months ended the third quarter. Quarterly profit before tax increased 107.1%, mainly because of the reversal of the one-off loss associated with the previous year’s business reorganization, while revenue from pharmaceutical development support services continued to decline. - FY2018-Q2Revenue down and profit up for the six months ended second quarterAnnual report
「Although the business reorganization in the previous consolidated fiscal year contributed revenue from the provision of medical representatives (MRs) to pharmaceutical companies, the substantial decline in revenue from the pharmaceutical development support business resulted in lower revenue year on year. On the profit side, quarterly profit before tax increased year on year, mainly because of the reversal of a one-off loss related to the business reorganization in the six months ended the second quarter of the previous fiscal year. As a result, revenue in the Other segment was ¥3,450 million, down 7.4% year on year, while quarterly profit before tax was ¥231 million, up 153.9%.」
The Other segment reported lower revenue and higher profit for the six months ended the second quarter. Revenue from pharmaceutical development support services continued to decline, while profit increased because of the reversal of the one-off loss associated with the previous year’s business reorganization. - FY2018-Q1First statedAnnual report
「Although the business reorganization in the previous consolidated fiscal year contributed revenue from the provision of medical representatives (MRs) to pharmaceutical companies, the substantial decline in revenue from the pharmaceutical development support business resulted in lower revenue year on year. On the profit side, profit before tax for the quarter increased year on year, mainly because of cost reductions resulting from the transfer of the pharmaceutical development support business. As a result, revenue in the Other segment was ¥1,741 million, down 5.7% year on year, while quarterly profit before tax was ¥169 million, up 96.1%.」
The Other segment reported lower revenue because of the transfer of the pharmaceutical development support business, while quarterly profit before tax increased 96.1% on cost reductions and other factors.